Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-31

Clinical Trial Update: Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Genotropin (somatropin) in short prepubertal children with intrauterine growth restriction has completed, with results posted in 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GENOTROPIN (SOMATROPIN)

Snippet

Sponsor: Pfizer | Conditions: Growth Disorders, Intrauterine Growth Retardation | Phase 3 | Status: COMPLETED | Results posted: 2010-08-31